1. Home
  2. GNSS vs MIST Comparison

GNSS vs MIST Comparison

Compare GNSS & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genasys Inc.

GNSS

Genasys Inc.

HOLD

Current Price

$2.17

Market Cap

98.4M

ML Signal

HOLD

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$2.04

Market Cap

176.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNSS
MIST
Founded
1992
2003
Country
United States
Canada
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.4M
176.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GNSS
MIST
Price
$2.17
$2.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$5.25
$8.50
AVG Volume (30 Days)
154.4K
10.1M
Earning Date
02-10-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,757,000.00
N/A
Revenue This Year
$83.82
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
69.76
N/A
52 Week Low
$1.46
$0.63
52 Week High
$3.73
$3.06

Technical Indicators

Market Signals
Indicator
GNSS
MIST
Relative Strength Index (RSI) 43.97 40.44
Support Level $2.15 $1.90
Resistance Level $2.30 $2.14
Average True Range (ATR) 0.12 0.32
MACD -0.00 -0.07
Stochastic Oscillator 50.00 28.62

Price Performance

Historical Comparison
GNSS
MIST

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: